Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The interview with Michel Verhasselt about the reimbursement of medical devices in Belgium

We have released the interview on the Market Access Insider channel on Youtube. Michel Verhasselt is the Founder and CEO of Meditech Access SAS.

The interview covered key stakeholders, reimbursement mechanism and pathways for procedures, implantable and invasive devices, coverage with evidence development program in Belgium. Michel shared a lot of first-hand insights from the reimbursement submissions in the country.

Watch the interview here.